BCR-ABL1 fusion due to t(9;22)(q34;q11.2) was observed in 9% Ph+ALL patients, but taking into consideration the whole ALL population, it was observed in only 0.3%. This evidence concerns the gene BCR and acute lymphoblastic leukemia.